Price $5.45 |
Market Cap
98.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.76
|
P/S
2.21
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
46.6
|
Op. Cash Flow
2.5K
|
FCF
0.1
|
|
Op. Margin
-11.50%
|
Net Margin
-10.60%
|
ROE
-8.10%
|
ROI
-9.80%
|
|
ROA
-4.60%
|
EPS Growth
47.60%
|
Current Ratio
2.1
|
Debt/Equity
35.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Allergan plc (AGN) | $163.16 | - | 1.80% | 53.76B | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $43.10 | - | - | 1.31B | Strong Buy |
| Premier Inc (PINC) | $39.18 | - | - | 4.88B | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $6.18 | - | - | 106.5M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $1.64 | - | - | 7.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
